Shazia K. Nakhoda, MD

Dr. Shazia Nakhoda

Assistant Professor, Department of Hematology/Oncology

Hematology-Lymphoma Program

Specialties

  • Hematology Oncology

Areas of Expertise

Myeloma, Lymphoma, Leukemia

Treatment Focus

Malignant Hematology; Central Nervous System Lymphoma

Distinctions

Treatment Philosophy

Navigating a new cancer diagnosis can be challenging and overwhelming. I feel honored to be part of a team that provides patients and their families not only specialized oncologic care, but also the support and resources needed. The collaborative network of clinicians, nurses, and researchers at Fox Chase allows me to provide my patients individualized treatment options, novel therapies, and access to clinical trials. In addition, I strive to provide my patients and their families compassionate and comprehensive clinical care throughout each aspect of their journey.

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427

Educational Background

  • Hematology & Oncology Fellowship Training, Temple University and Fox Chase Cancer Center, Philadelphia, PA, 07/2017-06/2020
  • Internal Medicine Residency Training, University of Maryland Medical Center, Baltimore, MD, 6/2014-06/2017
  • MD, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, 2014

Certifications

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Hematology
  • American Board of Internal Medicine - Medical Oncology

Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2024
  • Awarded Honorable Mention for the Arnold R. Weitz, M.D. Memorial Prize in Hematology, 2014

Selected Publications

Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment Strategies. Nakhoda SK, Olszanski AJ. Pharmaceut Med. 2020 Apr;34(2):83-91. doi: 10.1007/s40290-020-00326-z. PMID: 32157638

Use of the APACHE II score to assess impact of therapeutic plasma exchange for critically ill patients with hypertriglyceride-induced pancreatitis. Nakhoda S, Zimrin AB, Baer MR, Law JY. Transfus Apher Sci. 2017 Apr;56(2):123-126. doi: 10.1016/j.transci.2016.10.005. Epub 2016 Oct 17. PMID: 27789124 Clinical Trial.

Additional Publications

MyNCBI

Related Articles